(Q39068951)

English

Smac mimetic compound LCL161 sensitizes esophageal carcinoma cells to radiotherapy by inhibiting the expression of inhibitor of apoptosis protein

scientific article published on 30 October 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

8 September 2017

Smac mimetic compound LCL161 sensitizes esophageal carcinoma cells to radiotherapy by inhibiting the expression of inhibitor of apoptosis protein (English)

1 reference

Europe PubMed Central

8 September 2017

Adaptive radiation therapy

0 references

esophageal carcinoma

1 reference

based on heuristic

inferred from title

author name string

Qin Qin

1

1 reference

Europe PubMed Central

8 September 2017

Yun Zuo

2

1 reference

Europe PubMed Central

8 September 2017

Xi Yang

3

1 reference

Europe PubMed Central

8 September 2017

Jing Lu

4

1 reference

Europe PubMed Central

8 September 2017

Liangliang Zhan

5

1 reference

Europe PubMed Central

8 September 2017

Liping Xu

6

1 reference

Europe PubMed Central

8 September 2017

Chi Zhang

7

1 reference

Europe PubMed Central

8 September 2017

Hongcheng Zhu

8

1 reference

Europe PubMed Central

8 September 2017

Jia Liu

9

1 reference

Europe PubMed Central

8 September 2017

Zheming Liu

10

1 reference

Europe PubMed Central

8 September 2017

Guangzhou Tao

11

1 reference

Europe PubMed Central

8 September 2017

Shengbin Dai

12

1 reference

Europe PubMed Central

8 September 2017

Xizhi Zhang

13

1 reference

Europe PubMed Central

8 September 2017

Jianxin Ma

14

1 reference

Europe PubMed Central

8 September 2017

Jing Cai

15

1 reference

Europe PubMed Central

8 September 2017

Xinchen Sun

16

1 reference

Europe PubMed Central

8 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

30 October 2013

1 reference

Europe PubMed Central

8 September 2017

1 reference

Europe PubMed Central

8 September 2017

35

1 reference

Europe PubMed Central

8 September 2017

3

1 reference

Europe PubMed Central

8 September 2017

2565-2574

1 reference

Europe PubMed Central

8 September 2017

https://scigraph.springernature.com/pub.10.1007/s13277-013-1338-2

0 references

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1338-2

21 January 2018

High expression of survivin predicts poor prognosis in esophageal squamous cell carcinoma following radiotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1338-2

21 January 2018

IAP proteins: blocking the road to death's door

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1338-2

21 January 2018

NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1338-2

21 January 2018

The inhibitors of apoptosis (IAPs) as cancer targets

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1338-2

21 January 2018

siRNA targeting NBS1 or XIAP increases radiation sensitivity of human cancer cells independent of TP53 status

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1338-2

21 January 2018

Synthetic Smac/DIABLO peptides enhance the effects of chemotherapeutic agents by binding XIAP and cIAP1 in situ

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1338-2

21 January 2018

Sensitization for gamma-irradiation-induced apoptosis by second mitochondria-derived activator of caspase

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1338-2

21 January 2018

Structural and biochemical basis of apoptotic activation by Smac/DIABLO

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1338-2

21 January 2018

Molecularly targeted radiosensitization of human prostate cancer by modulating inhibitor of apoptosis.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1338-2

21 January 2018

Radiosensitization of head and neck squamous cell carcinoma by a SMAC-mimetic compound, SM-164, requires activation of caspases.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1338-2

21 January 2018

Smac-mimetic compound SM-164 induces radiosensitization in breast cancer cells through activation of caspases and induction of apoptosis.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1338-2

21 January 2018

BV6, an IAP antagonist, activates apoptosis and enhances radiosensitization of non-small cell lung carcinoma in vitro

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1338-2

21 January 2018

In vitro and in vivo radiosensitization of colorectal cancer HT-29 cells by the smac mimetic JP-1201.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1338-2

21 January 2018

Initial testing (stage 1) of LCL161, a SMAC mimetic, by the Pediatric Preclinical Testing Program

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1338-2

21 January 2018

Smac mimetics: implications for enhancement of targeted therapies in leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1338-2

21 January 2018

Apoptotic resistance to ionizing radiation in pediatric B-precursor acute lymphoblastic leukemia frequently involves increased NF-kappaB survival pathway signaling.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1338-2

21 January 2018

Inhibition of Bcl-2 improves effect of LCL161, a SMAC mimetic, in hepatocellular carcinoma cells.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1338-2

21 January 2018

The extrinsic cell death pathway and the élan mortel

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1338-2

21 January 2018

Sensitization of pancreatic carcinoma cells for γ-irradiation-induced apoptosis by XIAP inhibition

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1338-2

21 January 2018

Cellular inhibitor of apoptosis 1 and 2 are ubiquitin ligases for the apoptosis inducer Smac/DIABLO

1 reference

https://pubmed.ncbi.nlm.nih.gov/24170321

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of pleural fluid survivin and XIAP for the diagnosis of malignant pleural effusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/24170321

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeting of X-linked inhibitor of apoptosis protein or survivin by short interfering RNAs sensitize hepatoma cells to TNF-related apoptosis-inducing ligand- and chemotherapeutic agent-induced cell death.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24170321

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24170321

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of cIAP1, a target for 11q22 amplification, correlates with resistance of cervical cancers to radiotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24170321

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S13277-013-1338-2

1 reference

Europe PubMed Central

8 September 2017

1 reference

Europe PubMed Central

8 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39068951&oldid=1806500271"